Acute upper respiratory tract infection in children
Conditions
Interventions
Experimental Group:Pediatric Chiqiao Qingre Syrup, oral administration, 3 times daily, course of 3 days
1-3 years old: 15ml per dose, 4-6 years old: 20ml per dose, 7-9 years old: 25ml per dose, 10-13 years old: 30ml per dose.
Control Group:Pediatric Diquqing Heat Granules: dissolve in boiling water, take three times daily, for a 3-day course
dosage: 3 grams per dose for children aged 1-3 years, 4 grams per dose for 4-6 years, 5 grams per dose for 7-9 years, and 6 grams per dose for 10-13 years.
Sponsors
Central Hospital of Hunan University of Medicine and Health (formerly Huaihua City First People's Hospital)
Eligibility
Sex/Gender
All
Age
1 Years to 13 Years
Inclusion criteria
Inclusion criteria: 1. Age 1-13 years old, gender; 2. Meets the diagnostic criteria for acute upper respiratory tract infection in Western medicine; 3. Body temperature within 24 hours prior to consultation is 37.2? to 39? (including 37.2? and 39?), and fever duration =48 hours; 4. The legal guardian of the child signs the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Children with concurrent respiratory system diseases or pulmonary diseases; 2. Children with herpangina, pharyngoconjunctival fever, suppurative tonsillitis, lower respiratory tract infections, or respiratory infectious diseases; 3. Children with a history of epilepsy or febrile seizures, or recurrent respiratory infections; 4. Children with severe malnutrition, rickets, or concurrent severe systemic diseases such as cardiovascular, cerebral, hepatic, renal, or hematopoietic system disorders, or mental illness; 5. Children with known allergies to the components of the investigational drug; 6. Children who have participated in other clinical trials within the past three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body Temperature; | — |
Secondary
| Measure | Time frame |
|---|---|
| Complete defervescence time;Immediate fever reduction time;Traditional Chinese Medicine (TCM) Syndrome Efficacy; | — |
Countries
China
Contacts
Public ContactLuo Qilin
Central Hospital of Hunan University of Medicine and Health (formerly Huaihua City First People's Hospital)
Outcome results
None listed